Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
TargTex logo — Targeted Therapeutics

TargTex

Targeted Therapeutics

Founded 2019 Portugal Portugal 7 employees Seed AI, Biotechnology +3

General Information

Company Name TargTex
Founded Year 2019
Location Portugal Portugal
Employees 7
Industries AI, Biotechnology, Health Care +2
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with TargTex. To contact TargTex, visit targtex.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TargTex compare?

A PDF of TargTex and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TargTex soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TargTex

TargTex is a Portuguese biotech startup founded in 2019, utilizing a unique blend of academic research and medical expertise. The company's core technology, originating from Gonçalo Bernardes' research lab at Instituto de Medicina Molecular (iMM) of the University of Lisbon, is based on an artificial intelligence algorithm that deciphers biological target-molecule relationships. This led to the identification of an unexplored target for Glioblastoma (GBM), a challenging pathology. TargTex is developing a hydrogel-based solution for single-dose therapy as an adjunct to surgery for GBM, with the long-term goal of creating clinical candidates for various oncological indications.

Having received a Seed Round investment on 26 June 2019 from Portugal Ventures, TargTex aims to become a sustainable company, facilitating the development of other anticancer candidates. The company operates in the realms of AI, Biotechnology, Health Care, Health and Wellness, and Pharmaceutical industries, showcasing its potential to make a significant impact in the healthcare sector from its headquarters in Portugal. With its innovative approach and significant investment backing, TargTex is poised to play a crucial role in addressing challenging medical conditions, particularly in the field of oncology.

Business keywords: Biotech, Oncology, Therapeutics, Drug Development, Glioblastoma, Hydrogel Formulation, Clinical Trials, Small Molecules, Cancer Research, Portuguese Biotech, Research and Development, Medical Technology, Molecular Biology, Innovation

Services & Products

Developing Localized Therapies for Hard-to-Treat Tumors
Researching Novel Correlations between Small Molecules and Targets
Advancing Innovative Therapies against Daunting Diseases
Applying AI to Assess the Effects of Clinical Candidates in Glioblastoma Patients

Target Customers

Medical institutions Pharmaceutical Companies Patients with Hard-to-Treat Tumors

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Portugal Ventures
Portugal Ventures
26 Jun 2019

TargTex Alternatives & Competitors

View All Alternatives
TargTex vs
NeuroSense Therapeutics
NeuroSense Therapeutics United States

Creatively and diligently moving fast towards an effective treatment for people with ALS.

31 employees
Biotechnology, Health and Wellness
TargTex vs
R2M Pharma, Inc.
R2M Pharma, Inc. United States

R2M is a collaborative pharmaceutical company that works with you throughout the discovery and devel...

17 employees
Biotechnology, Health Care
TargTex vs
Pharvaris
Pharvaris Switzerland

Pioneering science for patient choice

IPO
168 employees
Biotechnology, Health Care
View all alternatives

FAQ About TargTex

Targeted Therapeutics
TargTex was founded in 2019.
TargTex is headquartered in Portugal.
TargTex operates in AI, Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on Biotech, Oncology, Therapeutics and Drug Development. Its customers include Medical institutions, Pharmaceutical Companies and Patients with Hard-to-Treat Tumors.
TargTex has approximately 7 employees.
TargTex has completed 1 funding round. The latest funding stage is Seed.
TargTex offers: Developing Localized Therapies for Hard-to-Treat Tumors, Researching Novel Correlations between Small Molecules and Targets, Advancing Innovative Therapies against Daunting Diseases, Applying AI to Assess the Effects of Clinical Candidates in Glioblastoma Patients.
Top alternatives and competitors to TargTex include NeuroSense Therapeutics, R2M Pharma, Inc., Pharvaris, Petra Pharma, Innolake Biopharm. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TargTex and NeuroSense Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TargTex, https://bouncewatch.com/company/targtex, updated 22 April 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout